World of DTC Marketing

SEPTEMBER 9, 2021

SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. The drug industry is trying to convince voters that government negotiations with drug companies will lead to less innovation.

Healthcare 222

Healthcare Healthcare Government Insurance 222

European Pharmaceutical Review

JULY 11, 2024

He has the right vision, skills and experience to lead our R&D organisation,” commented Rob Michael, Chief Executive Officer, AbbVie. He joined AbbVie in 2016 and was appointed as chief scientific officer in 2019.

Medicine 105

Medicine Medical Leads Training 105

Curzon Consulting

OCTOBER 17, 2024

Introduced in 2016, the competition enables AMBS MBA students to showcase their skills, innovative thinking, and problem-solving abilities. 17th October 2024 2 Minutes Curzon Consulting is thrilled to sponsor this year’s Alliance Manchester Business School Consultancy Case Competition.

Competition 52

Competition Consulting Recruitment Government 52

Pharmaceutical Technology

JUNE 30, 2022

Acoziborole was previously discovered by the company Anacor Pharmaceuticals, which Pfizer acquired in 2016. The post Neglected tropical diseases: non-profits lead the way as private sectors lags appeared first on Pharmaceutical Technology. Sanofi is also developing its Phase IIb/Phase III treatment acoziborole for the same indication.

Leads 64

Leads Pharma Medicine FDA 64

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. It dropped more than 15% in 2016 and followed that up with a 44% rise in 2017.

Food and Drug Administration 234

Food and Drug Administration FDA Pharmaceutical Food 234

Clarify Health

MAY 30, 2023

According to its most recent research brief, “The Kids Are Not Alright: Mental Health Utilization Among Children and Young Adults, 2016-2022,” hospital admissions for mental illnesses rose 124% among children and young adults from 2016 – 2022.

Healthcare 92

Healthcare Healthcare Education Transportation 92

Copyright Clearance Center

MAY 2, 2023

Speakers include Christine Kirkpatrick , Founder, GO FAIR US; Barend Mons , President, CODATA; and Erik Schultes , FAIR Implementation Lead, GO FAIR Foundation.

Government 97

Government Training Management Leads 97

Pharmaceutical Technology

MAY 18, 2023

The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain. Shortages can lead to medicine rationing and delay in critical treatments, with a significant impact on patient care.

Medicine 99

Medicine Specialization Networking Patients 99

Legacy MEDSearch

MARCH 15, 2023

Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

Pharmaceutical Technology

MAY 11, 2023

In 2016, BioNTech and Genentech, a part of Roche signed an agreement to develop personalised mRNA therapies in oncology. Autogene cevumeran is the lead candidate to come from this collaboration and is being evaluated in different solid tumours. A global randomised follow-up trial is planned.

Patients 138

Patients Leads 138

Clarivate

JUNE 4, 2024

Learn how a new module within InCites Benchmarking & Analytics can help you see the leading edge of research. For example, the United States National Science Foundation’s 10 Big Ideas, which first launched in 2016, highlight the importance of convergence research in solving society’s grand challenges.

Government 72

Government Leads Management Networking 72

Pharmaceutical Technology

APRIL 4, 2023

AD is the leading cause of dementia, which is an umbrella term for a series of syndromes that can lead to memory loss, cognitive decay, and behavioural change. This was the greatest number of designations awarded in the last ten years and was 40% greater than the previous peak of five designations in 2016.

FDA 98

FDA Specialization Leads Marketing 98

Spotio

MAY 10, 2023

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

B2B Sales 98

B2B Sales Prospecting Sales CRM 98

pharmaphorum

JULY 13, 2022

The alliance sees Bicycle and Genentech collaborate on the discovery and preclinical testing of bicyclic peptides, with the Roche company taking over after a lead drug candidate is selected for further development. Roche isn’t the only big pharma partner Bicycle has attracted for its bicyclic peptide technology.

Leads 97

Leads Manufacturing Pharma 97

World of DTC Marketing

SEPTEMBER 7, 2022

According to JAMA , “in a cross-sectional study, between May 1, 2016, and May 31, 2021, there were 207 cancer drug approvals in oncology and malignant hematology. This leads to a question; “where does it end?” The biggest battle arena by far is oncology. ” The U.S.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

JUNE 1, 2021

After aducanumab showed promise in 2016, Biogen launched two late-stage trials — then stopped them halfway through, in March 2019, when an analysis concluded the studies would not reach their goal of slowing cognitive and functional impairment in participants.

FDA 187

FDA Side effects Patients Doctors 187

European Pharmaceutical Review

JANUARY 9, 2024

The development of AI in and its application to the production process are all going to lead us into a new era where drugs are safer, more effective, and focused on treating patients. 2016; 85(4):2048-2050. 2016; 12(7):878. One of its most useful aspects is that answers to many questions come readily from data analysis.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

PM360

OCTOBER 25, 2023

It is the responsibility of state regulators to maximize the number of people in their state who benefit from this without waiting or expecting federal rescheduling to fix everything. What’s Next if Rescheduling is Approved? If rescheduling survives all these hurdles, there are still some major unknowns.

Food and Drug Administration 119

Food and Drug Administration FDA Medical Insurance 119

European Pharmaceutical Review

JULY 4, 2022

This strategic investment completes our offering in drug product and strengthens our position as a leading [contract development and manufacturing organisation] CDMO with an unparalleled breadth of offerings across scales and technologies,” commented Pierre-Alain Ruffieux, CEO, Lonza. .

Manufacturing 97

Manufacturing Marketing Leads Pharmaceutical 97

pharmaphorum

NOVEMBER 27, 2022

Why not lead?” Let’s lead by doing things – by making decisions to lead.” The Scottish Government has told parliament it will provide further details on how it is transforming genomics in Scotland by the end of this year and will publish a genomics strategy next year. Why do we always have to follow?

Patients 87

Patients Medicine Government Leads 87

Pharmaceutical Technology

MARCH 24, 2023

However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.

Competition 59

Competition Marketing FDA Physicians 59

European Pharmaceutical Review

JUNE 13, 2023

This then leads to progressive loss of renal function, according to a 2016 paper published in Nature Reviews Disease Primers. In IgAN, autoimmune reaction to an abnormal form of IgA results in formation of immune complexes that deposit in the kidney. These immune complexes trigger inflammation and kidney damage. The post £2.5b

Biopharma 52

Biopharma Safety Leads Pharmaceutical 52

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. Nina gained her MSc in Health Policy from Imperial College London in May 2016 and is a trustee for the Waldenström’s Macroglobulinemia UK charity. She is an SME in market access, rare disease and biosimilars.

Medicine 114

Medicine Management Marketing Leads 114

Pharmaceutical Technology

MARCH 29, 2023

The collaboration between the companies began in 2016, for the purpose of identifying modifying treatments for a wide range of neurodegenerative diseases. Evotec and Bristol Myers Squibb have extended and expanded their strategic partnership to develop a broadened neurodegenerative diseases programme pipeline.

Food and Drug Administration 52

Food and Drug Administration Medicine Food FDA 52

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology. ” But why sue now?

Sales 98

Sales Medicine Marketing Government 98

Clarify Health

SEPTEMBER 12, 2022

SAN FRANCISCO, September 12, 2022 – Clarify Health , a leading cloud analytics and value-based payments platform company, today announced the publication of new research on pediatric mental health in a brief titled, “ The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016 – 2021.”

Insurance 52

Insurance Patients Leads 52

European Pharmaceutical Review

OCTOBER 27, 2023

If achieved, this would boost the UK’s competitiveness as a leading international site for trials. This is according to a 2016 paper published in Clinical and Translational Oncology. Timeframes to set up trials were reduced (on average) by 15 percent within a year of the legislation coming into force.”

Ethics 105

Ethics Medicine Education Competition 105

Pharmaceutical Technology

NOVEMBER 8, 2022

Until 2016, Fulgent Therapeutics owned both Fulgent Pharma and Fulgent Genetics. The company claimed that its lead drug candidate, FID-007, has attained proof-of-concept in initial human clinical trials to treat multiple kinds of cancers, including head and neck, pancreatic, ampullary, non-small cell lung cancer and breast cancer.

Pharma 52

Pharma Marketing Medicine Leads 52

Legacy MEDSearch

NOVEMBER 28, 2022

Trauma/ER: The BodyTom 64’s unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite. The BodyTom 64 brings the power of innovative imaging to patients’ bedsides safely and efficiently. About NeuroLogica. NeuroLogica Corp.,

FDA 92

FDA Food and Drug Administration Electronics Recruitment 92

European Pharmaceutical Review

DECEMBER 14, 2023

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. Samantha leads study design and statistical analysis and has experience with the CPRD electronic health records database. 1,2 This signals a promising trend towards a more comprehensive and diversified approach in regulatory decision-making.

Medicine 116

Medicine Safety Competition Networking 116

pharmaphorum

SEPTEMBER 14, 2022

Baumann has been at the helm of Bayer since May 2016, when he took over from Marijn Dekkers, and has spent his entire career at Bayer, rising through the ranks of the company. Bayer has declined to comment on the rumours.

Pharma 87

Pharma Management Leads Marketing 87

pharmaphorum

JANUARY 29, 2023

Secondly, pressure on healthcare spending is leading to greater consolidation. Mergers and acquisitions are contributing to consolidation, with about 2,600 healthcare deals globally in 2022, up from 1,500 in 2016. Moreover, new types of investors are emerging that have not traditionally invested in healthcare in the past.

Healthcare 91

Healthcare Healthcare Manufacturing Marketing 91

Pharmaceutical Technology

JUNE 7, 2023

ACE 2016 is an anti-EGFR armed allogeneic gamma delta 2 T-cell therapy that targets epidermal growth factor receptor (EGFR)-expressing solid tumours. ACE1831 is an anti-CD20 armed allogeneic gamma delta 2 T-cell therapy now being evaluated in a Phase I trial in non-Hodgkin lymphoma patients.

Patients 59

Patients Leads Pharmaceutical 59

Clarivate

JANUARY 3, 2023

Starting with 12,160 Research Fronts, representing papers published and cited between 2016 and 2021, the next step was to select the fronts containing core literature that is both highly cited and recent – an indicator of particularly active and fast-moving research. Fields and nations.

Specialization 98

Specialization Side effects Management Medicine 98

Clarify Health

SEPTEMBER 12, 2022

SAN FRANCISCO, September 12, 2022 – Clarify Health , a leading cloud analytics and value-based payments platform company, today announced the publication of new research on pediatric mental health in a brief titled, “ The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016 – 2021.”

Insurance 52

Insurance Patients Leads 52

Scott’s Directories

JANUARY 28, 2022

A study conducted by IBM in 2016 found that bad data is leaching an astounding $3.1 Too much time can be spent chasing a lead in the wrong direction or adapting your company strategy only to find out that your reasoning was based on faulty information. Sourcing Data. trillion annually from the American economy. Lost in Translation.

Medical 52

Medical Leads Doctors Sales 52

Clarivate

AUGUST 2, 2022

The CIRS study found that the FDA approved the highest number of NASs in 2021, continuing its streak of being the leading NAS approver since 2017. The CIRS study found that the number of products approved by all six agencies decreased by 23% from 2012-2016 (56 NASs) to 2017-2021 (43 NASs). FDA continues to approve the most NASs.

Medicine 98

Medicine Food and Drug Administration FDA Healthcare 98